Repligen Corp. (RGEN)
Repligen Market Cap: 9.382B for Dec. 30, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Enovis Corp. | 1.581B |
| Teleflex, Inc. | 5.378B |
| Globus Medical, Inc. | 11.76B |
| Perspective Therapeutics, Inc. | 204.43M |
| Xtant Medical Holdings, Inc. | 107.47M |
Market Cap Related Metrics
| PE Ratio | 6460.08 |
| PS Ratio | 13.28 |
| Price to Book Value | 4.504 |
| Price to Free Cash Flow | 90.87 |
| Price | 166.67 |
| Earnings Yield | 0.02% |
| Operating PE Ratio | 201.26 |
| Normalized PE Ratio | 277.60 |